At Edinburgh Haemophilia Centre, there was a further reduction in the use of cryoprecipitate and an increase in NHS concentrate; some commercial concentrate was also used. Read more about At Edinburgh Haemophilia Centre, there was a further reduction in the use of cryoprecipitate and an increase in NHS concentrate; some commercial concentrate was also used.
At Edinburgh Haemophilia Centre, there was a reduction in the use of cryoprecipitate and an increase in the use of NHS concentrate, with both Factorate and Koate being used in larger quantities than before. Read more about At Edinburgh Haemophilia Centre, there was a reduction in the use of cryoprecipitate and an increase in the use of NHS concentrate, with both Factorate and Koate being used in larger quantities than before.
Dr Ludlam felt that he was not getting the supply of PFC material that had been agreed. Read more about Dr Ludlam felt that he was not getting the supply of PFC material that had been agreed.
Dr Boulton stated that Dr Ludlam was beginning to use less PFC material in favour of cryoprecipitate and that this was an encouraging trend. Edinburgh also sourced Factor VIII from Inverness and Glasgow. Read more about Dr Boulton stated that Dr Ludlam was beginning to use less PFC material in favour of cryoprecipitate and that this was an encouraging trend. Edinburgh also sourced Factor VIII from Inverness and Glasgow.
Dr Boulton continued to express concerns that Dr Ludlam's home therapy programme was using a large proportion of the allocation from PFC and that he may need to buy commercial Factor VIII if the usage pattern continued. Read more about Dr Boulton continued to express concerns that Dr Ludlam's home therapy programme was using a large proportion of the allocation from PFC and that he may need to buy commercial Factor VIII if the usage pattern continued.
Similar concerns regarding use of Factor VIII concentrates and purchase of commercial products were raised at the meeting of the Lothian Health Board Area Executive Group. Read more about Similar concerns regarding use of Factor VIII concentrates and purchase of commercial products were raised at the meeting of the Lothian Health Board Area Executive Group.
At the meeting with Dr Boulton, Dr Ludlam agreed to make additional efforts to keep within the monthly allocation of concentrate from PFC, while Dr Boulton reiterated his warning that there would be need to buy more commercial Factor VIII. Read more about At the meeting with Dr Boulton, Dr Ludlam agreed to make additional efforts to keep within the monthly allocation of concentrate from PFC, while Dr Boulton reiterated his warning that there would be need to buy more commercial Factor VIII.
Dr Boulton wrote to Professor Ludlam, warning that the South East Scotland Blood Transfusion Centre was at the limits of production of concentrates for home therapy and indicated that Professor Ludlam may consider the necessity for buying some commercial product. Dr Boulton also encouraged Professor Ludlam to maximise use of the cryoprecipitate programme. Read more about Dr Boulton wrote to Professor Ludlam, warning that the South East Scotland Blood Transfusion Centre was at the limits of production of concentrates for home therapy and indicated that Professor Ludlam may consider the necessity for buying some commercial product. Dr Boulton also encouraged Professor Ludlam to maximise use of the cryoprecipitate programme.
Professor Ludlam did not proactively raise the question of AIDS risks with patients. Read more about Professor Ludlam did not proactively raise the question of AIDS risks with patients.
Donor blood plasma was redirected from cryoprecipitate production to concentrate manufacture. Read more about Donor blood plasma was redirected from cryoprecipitate production to concentrate manufacture.